HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei-Wen Kuo Selected Research

Heart Failure

1/2022Perturbed ER homeostasis by IGF-IIRα promotes cardiac damage under stresses.
1/2021Antioxidant Sirt1/Akt axis expression in resveratrol pretreated adipose-derived stem cells increases regenerative capability in a rat model with cardiomyopathy induced by diabetes mellitus.
6/2019ERK1/2 mediates the lipopolysaccharide-induced upregulation of FGF-2, uPA, MMP-2, MMP-9 and cellular migration in cardiac fibroblasts.
1/2019High-density lipoprotein ameliorates palmitic acid-induced lipotoxicity and oxidative dysfunction in H9c2 cardiomyoblast cells via ROS suppression.
2/2018Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure.
1/2018ERβ targets ZAK and attenuates cellular hypertrophy via SUMO-1 modification in H9c2 cells.
1/2018Rab9-dependent autophagy is required for the IGF-IIR triggering mitophagy to eliminate damaged mitochondria.
1/2018Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy.
1/2017Enhancement of beta-catenin in cardiomyocytes suppresses survival protein expression but promotes apoptosis and fibrosis.
9/2016Anthocyanin Attenuates Doxorubicin-Induced Cardiomyotoxicity via Estrogen Receptor-α/β and Stabilizes HSF1 to Inhibit the IGF-IIR Apoptotic Pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei-Wen Kuo Research Topics

Disease

40Hypertrophy
02/2022 - 11/2004
39Cardiomegaly (Heart Hypertrophy)
02/2022 - 11/2004
31Neoplasms (Cancer)
02/2022 - 07/2006
28Fibrosis (Cirrhosis)
08/2022 - 10/2005
22Hypoxia (Hypoxemia)
10/2021 - 03/2007
18Hypertension (High Blood Pressure)
09/2022 - 01/2004
15Inflammation (Inflammations)
04/2022 - 05/2006
14Heart Failure
01/2022 - 05/2006
13Cardiomyopathies (Cardiomyopathy)
09/2021 - 10/2010
11Hepatocellular Carcinoma (Hepatoma)
01/2022 - 10/2006
10Hyperglycemia
08/2022 - 04/2012
10Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2009
9Diabetic Cardiomyopathies
12/2021 - 01/2011
9Heart Diseases (Heart Disease)
01/2021 - 10/2005
9Colonic Neoplasms (Colon Cancer)
01/2018 - 04/2006
9Neoplasm Metastasis (Metastasis)
01/2018 - 09/2006
8Cardiotoxicity
02/2022 - 09/2016
7Wounds and Injuries (Trauma)
01/2022 - 01/2016
7Mitochondrial Diseases (Mitochondrial Disease)
12/2021 - 02/2015
7Body Weight (Weight, Body)
09/2021 - 02/2003
7Colorectal Neoplasms (Colorectal Cancer)
05/2020 - 04/2006
6Myocardial Infarction
06/2019 - 05/2008
6Obesity
01/2019 - 10/2007
4Diabetes Mellitus
01/2021 - 09/2015
4Carcinogenesis
12/2019 - 11/2014
4Hyperlipidemias (Hyperlipidemia)
01/2019 - 01/2016
3Rheumatoid Arthritis
10/2022 - 05/2006
3Hyperplasia
01/2022 - 04/2021
3Parkinson Disease (Parkinson's Disease)
06/2020 - 11/2010
3Osteosarcoma (Osteogenic Sarcoma)
05/2020 - 04/2005

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
15Angiotensin IIIBA
09/2022 - 07/2006
14CalcineurinIBA
02/2022 - 12/2005
14Insulin-Like Growth Factor II (Somatomedin A)IBA
12/2021 - 07/2006
11Estrogen ReceptorsIBA
10/2020 - 07/2006
11Atrial Natriuretic Factor (ANF)IBA
10/2019 - 11/2004
10Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 04/2012
10Insulin-Like Growth Factor I (IGF-1)IBA
02/2015 - 09/2005
8CollagenIBA
10/2022 - 01/2011
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 09/2016
8Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2022 - 05/2008
8Pharmaceutical PreparationsIBA
01/2022 - 07/2014
8Insulin-Like PeptidesIBA
10/2021 - 05/2006
8Glucose (Dextrose)FDA LinkGeneric
10/2021 - 09/2013
8Streptozocin (Streptozotocin)FDA Link
09/2021 - 10/2010
8Matrix Metalloproteinases (MMPs)IBA
06/2019 - 05/2006
7IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
12/2021 - 07/2006
7Phosphotransferases (Kinase)IBA
12/2021 - 05/2009
7Estrogens (Estrogen)FDA Link
01/2018 - 09/2006
5Advanced Glycation End ProductsIBA
08/2022 - 08/2018
5Mitogen-Activated Protein KinasesIBA
02/2022 - 04/2005
5Sirtuin 1IBA
01/2022 - 01/2018
5Hematoxylin (Haematoxylon)IBA
01/2022 - 10/2007
5Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 10/2007
5Transcription Factors (Transcription Factor)IBA
01/2021 - 06/2008
5CateninsIBA
09/2019 - 08/2011
5Brain Natriuretic Peptide (Natrecor)FDA Link
01/2019 - 05/2008
4Protein Kinases (Protein Kinase)IBA
02/2022 - 04/2005
4Histone Deacetylase InhibitorsIBA
01/2022 - 01/2014
4Insulin-Like Growth Factor Binding Protein 3IBA
10/2021 - 01/2015
4diallyl trisulfideIBA
10/2021 - 02/2013
4TeaIBA
02/2021 - 03/2014
4Protein Phosphatase 1IBA
11/2020 - 04/2017
4Galactose (Galactopyranose)FDA LinkGeneric
01/2020 - 03/2016
4transcription factor NF-AT c3IBA
11/2019 - 01/2015
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2019 - 05/2009
4Plasminogen Activators (Plasminogen Activator)IBA
06/2019 - 05/2009
4CholesterolIBA
11/2017 - 09/2009
4Apoptosis Regulatory ProteinsIBA
01/2017 - 04/2008
4Tobacco Smoke Pollution (Passive Smoking)IBA
09/2016 - 10/2005
4Transforming Growth Factor beta (TGF-beta)IBA
05/2016 - 11/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 03/2007
4LipidsIBA
10/2015 - 04/2006
4Death Domain ReceptorsIBA
09/2009 - 10/2005
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
10/2022 - 11/2017
3Arecoline (Arecolin)IBA
02/2022 - 04/2013
3galanginIBA
01/2022 - 12/2017
3CalciumIBA
12/2021 - 07/2016
3Toll-Like Receptor 4IBA
09/2021 - 06/2013
3rhodamine-phalloidinIBA
07/2021 - 05/2008
3ResveratrolIBA
01/2021 - 01/2018
3AntioxidantsIBA
01/2021 - 09/2013
3Therapeutic UsesIBA
01/2021 - 02/2013
3MicroRNAs (MicroRNA)IBA
11/2020 - 01/2018
3Somatomedin Receptors (Somatomedin Receptor)IBA
01/2020 - 11/2016
3Protein Isoforms (Isoforms)IBA
12/2019 - 12/2016
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2019 - 12/2005
3Tissue Plasminogen Activator (Alteplase)FDA Link
06/2019 - 05/2009
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2019 - 06/2013
3NADPH Oxidases (NAD(P)H oxidase)IBA
01/2018 - 09/2013
3Estrogen Receptor alphaIBA
01/2018 - 09/2006
3oxidized low density lipoproteinIBA
11/2017 - 10/2009
3p38 Mitogen-Activated Protein KinasesIBA
08/2017 - 03/2007
3EnzymesIBA
04/2017 - 05/2009
3thymoquinoneIBA
02/2017 - 02/2015
3Dinoprostone (PGE2)FDA Link
02/2017 - 08/2011

Therapy/Procedure

18Therapeutics
10/2022 - 04/2006
6Oral Administration
07/2021 - 06/2013
5Drug Therapy (Chemotherapy)
01/2021 - 07/2014
4Transplantation
01/2022 - 11/2017